Literature DB >> 7426503

Effect of danazol on serum gonadotrophins and steroid hormone concentrations in women with menorrhagia.

T H Chimbira, A B Anderson, E Cope, A C Turnbull.   

Abstract

In 13 ovulatory women with objective evidence of menorrhagia (menstrual blood loss greater than 80 ml), danazol 400 mg given daily for 12 weeks suppressed ovulation as shown by absence of gonadotrophin peaks, low serum progesterone levels and flat basal body temperature recordings. Serum concentrations of luteinising hormone and follicle stimulating hormone were within the range found during the normal menstrual cycle but oestradiol concentrations tended to fall, reaching levels less than 100 pmol/l in some patients. Danazol treatment had no effect on levels of androstenedione or dehydroepiandrosterone and its sulphate. The presence or absence of cyclical bleeding on treatment, and the measured blood loss was unrelated to circulating oestradiol levels.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7426503     DOI: 10.1111/j.1471-0528.1980.tb04550.x

Source DB:  PubMed          Journal:  Br J Obstet Gynaecol        ISSN: 0306-5456


  4 in total

1.  A comparative study of danazol and norethisterone in dysfunctional uterine bleeding presenting as menorrhagia.

Authors:  M Bonduelle; J J Walker; A A Calder
Journal:  Postgrad Med J       Date:  1991-09       Impact factor: 2.401

2.  Endometriosis--continuing conundrum.

Authors: 
Journal:  Br Med J       Date:  1980-10-04

Review 3.  Risk-benefit assessment of drugs used for the treatment of menstrual disorders.

Authors:  J M Higham; R W Shaw
Journal:  Drug Saf       Date:  1991 May-Jun       Impact factor: 5.606

Review 4.  Heavy menstrual bleeding diagnosis and medical management.

Authors:  Intira Sriprasert; Tarita Pakrashi; Thomas Kimble; David F Archer
Journal:  Contracept Reprod Med       Date:  2017-07-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.